Clinical Use of Selected and Expanded Peripheral Blood CD34+ Cells: A Preliminary Report of Feasibility and Safety

Todd M. Zimmerman*, Stephanie F. Williams, James G. Bender, Wanda J. Lee, Mary Blake, Javier Carreon, Patricia Swinney, Stephen J. Smith, Marta Schilling, Fred Oldham, Dennis Van Epps, Douglas E. Williams

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Abstract

In this report, we describe the preliminary results from a feasibility and safety study on the clinical use of CD34-positive cells cultured from mobilized peripheral blood. Separation and cell expansion were successfully performed, and the patients tolerated the infusions without problems and achieved engraftment.

Original languageEnglish (US)
Pages (from-to)527-529
Number of pages3
JournalJournal of Hematotherapy and Stem Cell Research
Volume4
Issue number6
DOIs
StatePublished - Dec 1995
Externally publishedYes

ASJC Scopus subject areas

  • Immunology
  • Hematology

Fingerprint Dive into the research topics of 'Clinical Use of Selected and Expanded Peripheral Blood CD34+ Cells: A Preliminary Report of Feasibility and Safety'. Together they form a unique fingerprint.

Cite this